BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Johnson & Johnson (JNJ)'s Cordis Corporation (JNJ) Escapes $482 Million Verdict As Court Rejects Patent Appeal


1/27/2014 9:01:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The U.S. Supreme Court on Monday declined to hear an appeal from a radiologist seeking to reinstate a $482 million patent infringement award he had won against Cordis Corp. The decision leaves intact an appeals court ruling throwing out the 2011 jury award. In the April 2013 ruling, the U.S. Court of Appeals for the Federal Circuit said Cordis, a Johnson and Johnson subsidiary, did not infringe on a patent owned by the radiologist, Bruce Saffran, in making its Cypher stent.

Help employers find you! Check out all the jobs and post your resume.


Read at Reuters
Read at North Jersey

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES